Transcriptional targets of nuclear EGFR and HER-2, those identified thus far, are closely involved in tumorigenesis, and tumour proliferation and progression (Lin et al, 2001; Wang et al, 2004; Hanada et al, 2005; Lo et al, 2005a). The gene discussed is ERBB2; the disease is neoplasm.